PB1929: EFFICACY AND SAFETY OF ACALABRUTINIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: AN OPEN-LABEL, MULTICENTER PHASE 1/2 TRIAL

Detalles Bibliográficos
Autores principales: Yang, Shenmiao, Huang, Haiwen, Zhou, Keshu, Zhao, Xielan, Han#, Yan-Qiu, LI, Lindong, Butturini, Anna, Wang, Yiqiu, Liu, Xiaofeng, Lai, Peiqiong, LI, Jianyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430145/
http://dx.doi.org/10.1097/01.HS9.0000974536.21928.ec
Descripción
Sumario:

Ejemplares similares